Clavis Pharma entered a partnership agreement with Clovis Oncology Inc erect problem . Last November for further development and commercialization of Clavis Pharma drug candidate, CP-4126, currently in Phase II clinical development for the treatment of pancreatic cancer. CP-4126 is a novel, patented, lipid – conjugated form of the anti-cancer drug gemcitabine, which has the potential to improve treatment outcomes in a large subgroup of patients with pancreatic cancer and several other solid tumors.

Young adults ‘ blood lead levels to depression linked, Panic Disorder – appear Young adults with higher blood lead levels more severe depression and panic disorders, even if lead to result in exposure to levels generally considered safe, according to a report in The December issue of the Archives of General Psychiatry, one of the JAMA / Archives journals. Lead is a known neurotoxin that is found ubiquitously in the environment, in the air, water and dust, the authors write as background information in the article. The elimination lead from gasoline has decline in average decline in average blood levels, but remaining sources of exposure include paint, industrial processes, pottery and contaminated water. Research on the neurotoxic effects of low-level lead exposure has been in utero in utero and early childhood periods. When adult population have the neurotoxic effects of lead, especially in the context of occupational exposures investigated, with greater levels of exposure to scales than those experienced by the general population.

Know how Joins a Swimming Pool on Open Innovation towards Neglected Tropical DiseasesThe Massachusetts Institute of Technology today afford the first academic institution of the intellectual property at the Swimming on Open Innovation from Neglected Tropical Diseases has been. TO occurs Glaxo SmithKline and Alnylam Pharmaceuticals, in the contributing patent in the pool, by the BIO by BIO venture for Global Health . Of the Swimming Pool of Open Innovation aims to innovative and efficient drug research and development by the opening access to IP or know-how motivate them research into neglected tropical diseases. OF contribution any patent the pool is a critical step by any of the world’s leading research establishments to access to intellectual property for the use of neglected tropical diseases explorer.